3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
8
Myelodysplastic Syndromes
6
Leukemia, Myeloid, Acute
6
Precursor Cell Lymphoblastic Leukemia-Lymphoma
5
Lymphoma, Non-Hodgkin
5
Hodgkin Disease
4
Recurrence
3
Anemia, Refractory, with Excess of Blasts
3
Myeloproliferative Disorders
2
Myelodysplastic-Myeloproliferative Diseases
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Myelomonocytic, Juvenile
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Chronic-Phase
2
Leukemia, Myeloid, Accelerated Phase
2
Hematologic Neoplasms
2
Ganglioneuroblastoma
2
Burkitt Lymphoma
2
Waldenstrom Macroglobulinemia
1
Thrombocythemia, Essential
1
Smoldering Multiple Myeloma
1
Sezary Syndrome
1
Rectal Neoplasms
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Polycythemia Vera
1
Plasmablastic Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Interventions
Cyclophosphamide
4
Vincristine
3
Temozolomide
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
liposomal doxorubicin
2
ivosidenib
2
cabozantinib
2
X-Rays
2
Topotecan
2
Specimen Handling
2
Radiation
2
Phantoms, Imaging
2
Nuclear Medicine Department, Hospital
2
Irinotecan
2
Eflornithine
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
Melphalan
×
30 days
×
Clear all
No trials found.